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Abstract
Background: Fluoroquinolones are broad-spectrum antibiotics used to prevent and treat a wide range of bacterial
infections. Plasmid-mediated qnr genes provide resistance to fluoroquinolones in many bacterial species and are
increasingly encountered in clinical settings. Over the last decade, several families of qnr genes have been
discovered and characterized, but their true prevalence and diversity still remain unclear. In particular,
environmental and host-associated bacterial communities have been hypothesized to maintain a large and
unknown collection of qnr genes that could be mobilized into pathogens.
Results: In this study we used computational methods to screen genomes and metagenomes for novel qnr genes.
In contrast to previous studies, we analyzed an almost 20-fold larger dataset comprising almost 13 terabases of
sequence data. In total, 362,843 potential qnr gene fragments were identified, from which 611 putative qnr genes
were reconstructed. These gene sequences included all previously described plasmid-mediated qnr gene families.
Fifty-two of the 611 identified qnr genes were reconstructed from metagenomes, and 20 of these were previously
undescribed. All of the novel qnr genes were assembled from metagenomes associated with aquatic environments.
Nine of the novel genes were selected for validation, and six of the tested genes conferred consistently decreased
susceptibility to ciprofloxacin when expressed in Escherichia coli.
Conclusions: The results presented in this study provide additional evidence for the ubiquitous presence of qnr genes
in environmental microbial communities, expand the number of known qnr gene variants and further elucidate the
diversity of this class of resistance genes. This study also strengthens the hypothesis that environmental bacterial
communities act as sources of previously uncharacterized qnr genes.
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Background
Fluoroquinolones are widely used synthetic broad-
spectrum antibiotics that inhibit the type II topoisomerase
complexes essential for bacterial DNA replication. There
are three main mechanisms of resistance to fluoroquino-
lones: 1) mutations in the target enzyme reducing the
binding affinity of the antibiotic, 2) efflux pumps facilitating
export of the antibiotic, and 3) qnr genes encoding proteins
thought to sterically prevent the antibiotic to interact with
the topoisomerase enzymes [1]. In contrast to fluoroquino-
lone resistance mechanisms such as chromosomal muta-
tions and efflux pumps, qnr genes are often located on
mobile plasmids and can be shared between bacterial cells
through the process of horizontal gene transfer. The first
plasmid-mediated fluoroquinolone resistance gene family,
qnrA, was discovered in 1998 [2], and since then, five add-
itional families have been described: qnrS [3], qnrB [4],
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qnrC [5], qnrD [6], and most recently qnrVC [7]. Novel var-
iants within the established families have been reported
over the last years, bringing the current total number of
mobile qnr gene variants across all families to 115 [8]. In
addition, sequence homology searches have revealed qnr
genes on chromosomes from a wide range of bacterial
species [9, 10]. Similarly to many other resistance genes,
qnr genes are hypothesized to have originated from
harmless environmental bacteria and subsequently mobi-
lized into human pathogens [11–13]. Recent reports sug-
gest that qnr genes are ubiquitously present in microbial
communities from many environments, including marine
and lake water, soil, river sediment, and the human micro-
biome [11, 14–17]. It is therefore possible that these com-
munities also maintain a large collection of novel qnr genes
that have not yet been transferred to, or discovered in,
pathogenic bacteria. Describing this unknown diversity of
qnr genes is important to fully understand their biological
and ecological roles. It also has the potential to uncover
currently undescribed resistance genes that might appear in
clinical settings in the future [18–20].
Modern high-throughput DNA sequencing technologies
have enabled direct analysis of the DNA from bacterial
communities without the need for cultivation of individual
isolates. The resulting metagenomic data provides infor-
mation on the combined set of genes maintained by the
microorganisms present in the sample [21, 22]. In Bou-
lund et al. (2012) we used a computational method to
screen nucleotide sequences from metagenomes for novel
qnr genes. By analyzing approximately 700 gigabytes of se-
quence data, evidence of several novel qnr genes could be
identified. Two of the identified genes selected for experi-
mental validation were confirmed to confer decreased
fluoroquinolone susceptibility in an E. coli model system
[23]. Over the last years, the body of metagenomic data
has grown, much thanks to the continuously increasing
throughput of shotgun sequencing technologies [24, 25].
In particular, the widely used Illumina sequencing
platforms have provided the ability to characterize bacter-
ial communities at an unprecedented sequencing depth
[26, 27]. However, the generated metagenomic sequencing
data is extensive and highly fragmented, and the identifi-
cation of novel qnr genes therefore requires computation-
ally efficient methods with high sensitivity and specificity.
In this report, we expand upon the work presented in
Boulund et al. (2012). Here, we modified and improved
the approach and also analyzed a substantially larger
data set containing more than 12 terabases of sequence
data from bacterial genomes and metagenomes. We
identified 362,843 qnr gene fragments from which 611
qnr gene sequences could be reconstructed. In total 52
qnr genes were reconstructed from metagenomic data,
and 20 of these were predictions of novel and previously
undescribed qnr variants. Nine novel qnr genes were
selected for experimental validation, and six of these
(88.8%) conferred consistently reduced susceptibility
against fluoroquinolone in E. coli.
Methods
In this study, we applied an extended and improved ver-
sion of the method for identification of novel resistance
genes described in Boulund et al. (2012). The method has
been extensively validated on short nucleotide fragments
produced by next generation sequencing platforms [10].
In particular, the sensitivity to identify 100 nucleotide long
fragments from novel qnr genes is 94% with a specificity
of 99.8% against other non-qnr pentapeptide repeat pro-
teins. Details for the performance for individual qnr clas-
ses are available in Boulund et al. 2012 [10]. The original
method operated by translating each nucleotide sequence
into amino acids in all six reading frames. Then, a profile
hidden Markov model (HMM), based on a multiple align-
ment of 66 well-characterized plasmid-mediated qnr
genes, was used to score each fragment based on its se-
quence [10]. Discrimination between fragments from qnr
genes and fragments of other origins (including fragments
from pentapeptide proteins without fluoroquinolone re-
sistance phenotype) was done by a classifier based on
alignment bit score and fragment length. Finally, a cluster-
ing step was used to group the qnr fragments into clusters
representing full-length genes. Complete details are avail-
able in Boulund et al. (2012). In this work, we have ex-
tended the previous method to make it applicable to
larger volumes of data than was feasible before. In particu-
lar, the management of the input sequence data has been
optimized by minimizing the storage of translated amino
acid sequence data and other intermediate files. The last
step, where the previous approach clustered all identified
putative qnr fragments, has also been modified. The reads
classified as containing qnr fragments are now assembled
using metagenome assembly methods, instead of merely
clustering them. This makes the method applicable to lar-
ger sets of fragmented DNA sequence data, such as those
commonly produced in recent metagenomic studies,
characterized by short-read high-throughput sequencing
techniques (e.g. Illumina sequencing).
In this study, the HMM-based method was used to search
for the presence of new qnr genes in a large collection of
nucleotide sequence data sets, including metagenomes
(from human-associated microbial communities, polluted
environments, and waste water treatment plants), fully as-
sembled bacterial genomes, and assorted nucleotide se-
quences from public repositories (e.g. NCBI Genbank). All
sequence data (Table 1) were downloaded between May and
December 2015 and processed as follows. Sequence files in
FASTQ format were quality filtered and converted to
FASTA using the FASTX-toolkit version 0.13.2 [28]. Quality
filtering was performed with fastq_quality_filter; option: “-q
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30”, and FASTQ to FASTA conversion was done with fas-
tq_to_fasta (default settings). All nucleotide data was trans-
lated into peptide sequences in all six reading frames using
EMBOSS transeq version 6.3.1 [29]; options: “-frame 6
-Table 11”. After translation, HMMER3 (hmmsearch) ver-
sion 3.1b1 [30] was used together with the hidden Markov
model constructed from experimentally verified plasmid-
mediated qnr genes [10] to search the data sets for the pres-
ence of qnr fragments; options: “–domtblout -E 1000
–domE 1000”. All fragments matching the HMM were fil-
tered using the fragment length dependent filtering criteria
from Boulund et al. (2012). Both read pairs were retrieved
for each fragment passing the filtering (even if only one of
them matched the HMM), and then used in gene assembly
for each individual data set. The paired-end reads were
trimmed using Trim Galore! [31] version 0.4.1, using default
settings. Assembly of the filtered retrieved paired-end reads
was done using the SPAdes assembler version 3.7.0, option:
“–meta”. The contigs produced in the assembly were then
scored and evaluated against the HMM, using the same
length dependent filtering criteria as above, to further valid-
ate each assembled sequence.
Nine assembled full-length sequences were selected for
experimental validation, based on their novelty (no identical
sequences in publicly available databases such as NCBI
GenBank) and similarity to previously described qnr vari-
ants (priority given to sequences with high similarity to
plasmid-mediated qnr). Predicted genes were considered
novel based on the criteria presented in Jacoby et al. (2008)
[32]. The qnr gene candidates were synthesized with KpnI
and BamHI restriction sites attached to the 5′ and 3′ ends,
respectively. The genes were subcloned into the expression
Table 1 Summary of the findings and data sets searched in this study
Data set Size (nt) Sequences Median
seq.
Length
Number of
qnr
fragmentsa
Assembled qnr sequences >200 aab
Metagenomic Previously known Putatively novel
Human microbiomes [43] 3.69 × 1012 3.90 × 1010 93 83,485
(2.14 × 10−6)
1 0
Human intestinal tract [34] 3.71 × 1011 5.22 × 109 75 12,966
(2.49 × 10−6)
0 0
Human intestinal tract [53] 7.10 × 1010 4.41 × 108 148 264
(5.99 × 10−7)
1 0
Waste water treatment plant [54] 4.82 × 1011 5.18 × 109 101 19,458
(3.76 × 10−6)
4 2
Antibiotic-polluted Indian lake [55] 6.75 × 109 6.68 × 107 101 57,415
(8.59 × 10−4)
5 0
Antibiotic-polluted Indian soil [35] 4.73 × 1010 4.68 × 108 101 840
(1.80 × 10−6)
0 0
Antibiotic-polluted Indian river sediment [56] 3.89 × 1010 3.85 × 108 101 67,021
(1.74 × 10−4)
4 1
Indian well water [35] 7.32 × 1010 7.25 × 108 101 1704
(2.35 × 10−6)
3 0
Oil spill [57] 2.75 × 1011 2.72 × 109 101 12,533
(4.60 × 10−6)
0 3
Pune river sediments [58] 3.9 × 1011 3.11 × 109 126 4805
(1.55 × 10−6)
5 4
Wadden sea [59] 8.4 × 109 5.23 × 107 161 723
(1.38 × 10−5)
0 5
Tara oceans [60] 7.20 × 1012 7.25 × 1010 101 100,795
(1.39 × 10−6)
2 5
Other
NCBI nt 5.22 × 1010 2.07 × 107 740 709
(3.42 × 10−5)
466 42
NCBI RefSeq bacterial 9.63 × 109 5.24 × 103 1,176,248 54
(1.03 × 10−2)
49 2
NCBI env_nt 9.55 × 109 2.07 × 107 117 71
(3.43 × 10−6)
3 4
Totals: 1.27 × 1013 1.30 × 1011 N/A 362,843
(2.79 × 10−6)
611 72
aRelative abundance given in parenthesis
bBoth putatively novel and previously known sequences are included in this listing
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vector pZE21 (EXPRESSYS, Ruelzheim, Germany) under
the control of the inducible promoter PLtetO-1 by utilizing
the attached restriction sites [33]. The generated plasmids
were electroporated into E. coli C600Z1 (EXPRESSYS). Pre-
viously described C600Z1 strains harboring pZE21 plas-
mids without any gene insert or with either qnrA1, qnrB1,
or qnrVC1 inserted, were included as controls [23]. The
strains carrying the different pZE21 plasmids were cultured
overnight on Mueller-Hinton agar (MHA) (Oxoid, Basing-
stoke, UK) supplemented with kanamycin (50 μg/mL) and
subjected to ciprofloxacin susceptibility testing with Etest®
gradient strips (BioMérieux SA, Marcy l’Etoile, France) ac-
cording to the manufacturer’s instructions. The tests were
performed on MHA containing the inducer anhydrotetra-
cycline (250 ng/mL) as well as on unsupplemented MHA.
E. coli ATCC 25922 was used as quality control strain.
Results
In total, 12.7 terabases of nucleotide data distributed over
130 billion sequences were screened for novel qnr genes.
The data consisted of metagenomes (12.7 terabases;
99.41%), NCBI RefSeq bacterial genomes (9.63 gigabases;
0.08%) and the NCBI nt database (62 gigabases; 0.41%)
(Table 1). In total, 362,843 sequences were classified as
fragments from qnr genes, which corresponded to an
overall relative abundance of 2.79 × 10−6. The abundance
of qnr gene fragments in metagenomes ranged from
5.99 × 10−7 to 8.59 × 10−4, where the highest levels were
found in samples from river and lake sediments contami-
nated with fluoroquinolones (Table 1). The method identi-
fied 611 different qnr gene sequences longer than 200
amino acids across all data sets. As expected, most of the
sequences (559; 91.5%) were previously characterized qnr
sequences present in NCBI GenBank and NCBI RefSeq
bacterial. Of these, 78 sequences were not previously an-
notated as qnr genes (Additional file 1: Table S1). Of the
5232 analyzed genomes, 49 (0.93%) carried qnr genes. In
particular, three genes were found in the chromosomes of
Vibrio nigripulchritudo str SFn1 (NC_022543.1), Vibrio
campbellii ATCC BAA 1116 (NC_022270.1) and Serratia
liquefaciens ATC 27592 (NC_021741.1). These species
have to the authors’ best knowledge not been previously
reported in the literature to carry qnr genes. A total of 52
(8.51%) full-length sequences were assembled from meta-
genomic data, out of which 20 were putatively novel qnr
genes (either not present or not annotated as a fluoro-
quinolone resistance gene in Genbank). Full-length qnr
genes (>200 aa) were assembled from all data sets but
two: one with human gut metagenomes [34] and one with
soil metagenomes [35]. All predicted qnr sequences are
presented in (Additional file 2).
The 20 novel qnr-like sequences identified in this work
had a length between 206 and 223 amino acids and showed,
on average, 57.12% amino acid sequence identity to previously
described plasmid-mediated qnr genes (Table 2). Out of the
20 novel qnr sequences identified, nine assembled full-
length sequences were selected for experimental validation
by gene synthesis and transformation into an E. coli host.
Induced expression of six of the selected sequences resulted
in an up to 11-fold increase of the ciprofloxacin minimum
inhibitory concentration (MIC) (0.016 to 0.19 mg/L) (Fig.
1). No increase in MIC could be seen for Wadden 4, while
Wadden 5 and Oil spill 2 showed inconsistent results be-
tween the replicated experiments. Phylogenetic analysis
showed that all of the validated genes formed their own
clades within the span of the established plasmid-mediated
qnr families. Sequences Wadden 3 and Wadden 4 formed
one small subclade, as did Oil spill 2 and Oil spill 3. All
other validated genes formed their own individual clades. A
complete tree containing: 1) all sequences discovered in this
work, 2) all plasmid-mediated qnr, and 3) mfpa, is available
as an additional figure (Additional file 3: Figure S1).
Discussion
In this report, we developed an improved computational
approach, appropriate also for deeply sequenced short-
read metagenomes, and applied it to screen for new qnr
genes in collections of DNA sequence data almost total-
ing 13 terabases. In contrast to what we previously
achieved in [10], this study screened an almost 20 times
larger dataset, this time dominated by short read meta-
genomic data produced by next generation DNA se-
quencing. This also makes this study, to the authors’
best knowledge, the largest and most exhaustive screen-
ing of novel qnr genes in publicly available nucleotide
sequence datasets to date. Our study shows that qnr-like
genes are widespread in different environments and
thus, supports the notion that qnr genes could have
originated from harmless environmental bacteria. We
identified 20 potentially new, full-length gene sequences,
all from metagenomic datasets, which have previously
not been described or associated with fluoroquinolone
resistance. Validation experiments, where the identified
putative novel qnr genes were expressed in an E. coli
host, were used to confirm the fluoroquinolone resist-
ance phenotype for six out of nine selected genes, re-
inforcing confidence in the performance of the
predictive model.
The general method applied in this work has previ-
ously been shown to reliably predict novel qnr genes in
sequence data. In particular, extensive cross-validation
experiments have demonstrated high true positive rates
while maintaining low false positive rates, even for nu-
cleotide fragments as short as 100 bases [10]. Previous
predictions based on this method have been experimen-
tally shown to provide increased fluoroquinolone resist-
ance, yielding minimum inhibitory concentration in the
same range as other qnr genes, when expressed in E. coli
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Table 2 Assembled putatively novel qnr sequences discovered in metagenomic datasets
Source data set Identifier Assembled
sequence
length (aa)
Average
measured MIC
(mg/L)
Most similar
plasmid-
mediated qnr
Identity with
most similar
pm-qnr (%)
Best match in Genbank
(% identity)
Comment
Human microbiomes
[43]
HMP 1 206 - QnrB10 and
QnrB62
97.04 AFY16910.1(98%) Possible misassembly:
Stop codon in
position 30
WWTP [54] WWTP 1 207 - QnrB15 61.76 WP_056930987.1(94%)
WWTP [54] WWTP 2 220 - QnrA3 47.93 WP_025325370.1(95%) 10 aa difference to
chromosomal variant
WWTP [54] WWTP
3a
220 - QnrA3 47.93 WP_005328535.1(100%) Identical to sequence in
Genbank
WWTP [54] WWTP
4a
219 - QnrA3 46.76 WP_041212172.1(100%) Identical to sequence in
Genbank
Antibiotic-polluted
Indian lake [55]
Lake 1a 220 - QnrVC4 99.54 WP_000361703.1(100%) Identical to sequence in
Genbank
Antibiotic-polluted
Indian river sediment
[56]
APRS 1a 220 - QnrVC4 99.54 WP_000361703.1(100%) Identical to sequence in
Genbank; Lake 1
Antibiotic-polluted
Indian river sediment
[56]
APRS 2 207 - QnrA3 47.06 WP_041212172.1(99%) Missing start codon
Indian well water
[35]
Well 1a 220 - QnrVC4 99.54 WP_000361703.1(100%) Identical to sequence in
Genbank
Oil spill [57] Oilspill 1 220 0.037 QnrVC1 65.44 WP_019613380.1 (82%)
Oil spill [57] Oilspill 2 220 0.025 QnrVC1 64.98 WP_019613380.1 (80%)
Oil spill [57] Oilspill 3 220 0.034 QnrVC1 62.21 WP_057181431.1(77%)
Pune river sediments
[58]
Pune 1 217 - QnrB27 62.15 WP_056930987.1(95%)
Pune river sediments
[58]
Pune 2 219 - QnrA3 47.69 WP_005340643.1(99%) 1 aa difference to
chromosomal variant
Pune river sediments
[58]
Pune 3 220 - QnrA3 49.77 WP_044798915.1(99%) 3 aa difference to
AhQnr
Pune river sediments
[58]
Pune 4a 219 - QnrA3 46.76 WP_042864588.1(100%) Identical to sequence in
Genbank
Wadden sea [59] Wadden
1
220 0.16 QnrVC5 73.73 WP_036748004.1(76%)
Wadden sea [59] Wadden
2
220 - QnrVC6 73.73 WP_007624600.1(75%)
Wadden sea [59] Wadden
3
219 0.029 QnrA6 62.96 WP_009385382.1(77%)
Wadden sea [59] Wadden
4
219 0.014 QnrVC7 66.67 WP_009385382.1(76%)
Wadden sea [59] Wadden
5
220 0.073 QnrA3 57.14 WP_006228785.1(66%)
Tara oceans [60] Tara 1a 219 - QnrVC1 60.65 WP_005374358.1(100%) Identical to sequence in
Genbank
Tara oceans [60] Tara 2 222 0.045 QnrA3 52.29 WP_045976340.1(60%)
Tara oceans [60] Tara 3 220 0.032 QnrVC5 53.46 WP_012534242.1(58%)
Tara oceans [60] Tara 4 223 - QnrS2 32.57 BAH90541.1(49%)
Tara oceans [60] Tara 5 220 - QnrA2 32.72 EPJ45142.1(38%)
Tara oceans [60] Tara 6 221 - QnrA3 31.19 EPJ45142.1(37%)
aAssembled sequence identical to already existing sequence in Genbank
Boulund et al. BMC Genomics  (2017) 18:682 Page 5 of 9
[23]. Moreover, the method was able to identify all
known plasmid-mediated and chromosomally located
qnr genes in NCBI Genbank and RefSeq, further under-
lining the validity of the predictions. In addition, three
families of qnr genes (qnrD, qnrS and qnrVC) were iden-
tified and fully assembled from the metagenomes sam-
pled from fluoroquinolone polluted river sediments
collected up and downstream from an industrial waste
water treatment plant in Patancheru, near Hyderabad,
India [15, 36, 37]. These specific gene families have pre-
viously been shown to be the most abundant in these
samples using other molecular techniques, such as 454
pyrosequencing and quantitative PCR [15, 35]. The ac-
curacy of the method was further emphasized by the fact
that six out of nine tested genes consistently conferred
the predicted resistance phenotype in E. coli. Thus, taken
together, our results show that the method is reliable and
can correctly identify known and unknown qnr genes
present in fragmented sequence data. This also implies that the
great majority of the genes found in this study that were
not validated are also likely to be correctly predicted
functional qnr genes.
Our results show that qnr genes are present in the bacter-
ial chromosomes of 49 (0.93%) of the 5242 analyzed ge-
nomes from RefSeq (Additional file 2; Additional file 4:
Table S2). This agrees well with reports from previous stud-
ies showing that qnr genes are carried by a wide range of
different bacterial species [9, 10, 14, 38, 39]. Chromosomal
and plasmid-mediated qnr genes have also been shown to
be almost ubiquitously present in e.g. soil, sediment,
aquatic, and human microbiomes [9, 10, 14, 38, 39], which
is reflected in our analysis, where fragments from potential
qnr genes were identified in all examined metagenomes.
Metagenomes from river and lake sediments polluted by
fluoroquinolones had the highest abundance of qnr frag-
ments, suggesting that a continuous selection pressure ef-
fectively enriches for resistance genes, increasing their
relative abundance in the sequenced communities. Interest-
ingly, qnr gene abundances were especially low in the meta-
genomes from the human microbiome (Table 1). This is in
line with previous studies that have demonstrated low
abundances of the six known plasmid-mediated qnr gene
families in the human gut microflora [17, 40, 41]. Of the
80,000 potential fragments identified in the Human Micro-
biome Project (764 samples from 300 individuals), only the
previously characterized qnrB62 was fully reconstructed.
Instead, the majority of the fragments assembled into con-
tigs that, based on their full length sequences, were not
classified as qnr and thus disregarded in the analysis. This
indicates that a large proportion of the fragments identified
in the human microbiome are likely to be false positives
and thus not from true qnr genes. One possible explanation
for the lack of fully reconstructed qnr genes from the hu-
man microbiome data could be that the abundance of qnr
genes is very low. This, possibly combined with a high spe-
cies diversity between individuals [34, 42–44], may nega-
tively influence our ability to completely assemble any qnr
genes from these data. Our results indicate, however, that
no known or novel qnr genes are ubiquitously spread in
high abundance across the metagenomes of the individuals
included in this study, suggesting that horizontally transfer-
rable qnr fluoroquinolone resistance genes are rare in the
human microbiome. Studies using qPCR, however, indicate
that qnr genes can be more common in the fecal flora of
people from certain regions, e.g. India [35].
Out of the sequences validated in our E. coli model, all but
three caused an increased MIC of ciprofloxacin in E. coli when
overexpressed. The strain carrying the sequence Wadden
Fig. 1 Gene tree showing the relationships between previously known plasmid-mediated qnr sequences and the sequences validated in this
work. The gene tree was produced with ETE 3 using the “standard_fasttree” workflow [50–52]. The non-qnr peptapeptide repeat protein MfpA
was used as an outlier to root the tree. The bar plot shows fold change of ciprofloxacin minimum inhibitory concentrations for all the tested
sequences from three separate measurements each. MIC values for QnrD1, QnrS1, and QnrC for the first time point were taken from our previous
study [23]. Wadden 4 did not display an average increase in MIC. Refer to Table 2 for a detailed listing of all sequences discovered in this work,
and to Additional file 5: Table S3 for the raw MIC measurement data
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4 showed no increase in MIC. For Wadden 5 and Oil spill
2, an increase in MIC was only detectable in one and two
of the three experiments, respectively. This suggest that
these three genes may lack the ability to induce a resist-
ance phenotype to ciprofloxacin. However, the phylogen-
etic analysis showed that all these three genes were not
more distant to the known mobile qnr genes than other
genes predicted in this study. For example, Wadden 4
formed a small subclade together with Wadden 3, which
provided a minor (2-fold) increase in MIC. This may sug-
gest some of these genes were not expressed properly in
our assay. However, all other validated sequences exhib-
ited average MIC fold changes between 2 to 10.6, which is
in line with representatives of the plasmid-mediated qnr
families that were also included in the validation for refer-
ence [45]. Indeed, several of the novel qnr genes identified
in this study resulted in an increase of the MIC close, or
in some cases, above previously identified mobile qnr
genes. For example, Wadden 1 had an average fold change
in MIC of 10.6 (as high as 15.8 in one experiment), which
was larger than QnrA1, QnrC, QnrD1, QnrS1 and
QnrVC1. In addition, Tara 2 demonstrated an increase in
MIC (2.9) that was higher than QnrA1. Thus, our results
suggest that several of the novel qnr genes identified in
this study may, if transferred into pathogens, become fu-
ture clinical problems and contribute to the growing num-
ber of bacteria resisting antibiotic treatment.
The evolutionary distance between the established
plasmid-mediated qnr gene families is known to be large
and the sequence identity between different variants can be
as low as 37.61%, as observed between QnrB24 and QnrS5
[46]. Identification of novel qnr gene families therefore re-
quires alignment strategies with high sensitivity and speci-
ficity. The computational approach used in this study is
based on profile HMMs implemented in HMMER3 [30].
Profile HMMs incorporate sequence variability by describ-
ing position-specific amino acid distributions and their
short-range dependencies, where the parameters are typic-
ally estimated from a multiple alignment of a set of repre-
sentative sequences. It should, however, be pointed out
that qnr genes exhibits a wide range of other properties
that are not specifically modelled by the profile HMM used
in this study. One such example is the recently discovered
external surface loops, i.e. short regions of the amino acid
residue chain that protrude out of the side of the otherwise
regular β-helix structure, observed in the majority of the
available mobile qnr gene structures [47, 48]. Incorporating
information about the fold of the protein requires model-
ling of long-range dependencies that are hard to accurately
capture in an HMM. It might therefore be possible to de-
velop a more sophisticated model that could increase the
sensitivity and specificity even further. However, increasing
model complexity often comes at the cost of a higher com-
putational burden. The profile HMM implemented in
HMMER3 provides both satisfactory sensitivity and specifi-
city in combination with high computational performance,
making it well suited for application to large amounts of
metagenomic sequencing data.
The amount of nucleotide data screened in this work
presents substantial computational challenges. In par-
ticular, a large proportion of the data (99.44%) consists
of metagenomic DNA sequences that are highly frag-
mented. A common approach when analyzing this type
of data is to assemble each metagenome prior to ana-
lysis. However, de novo assembly of large data sets is a
daunting task that quickly becomes unfeasible because
of the computational and memory complexity, in the
worst case, exhibiting quadratic growth with increasing
number of fragments [49]. Assembly of all the data in-
cluded in this study would therefore be highly impracti-
cal. Instead, our method essentially applies a data
reducing filtering approach where fragments unlikely to
represent qnr genes (based on similarity to the HMM)
are excluded prior to assembly. This provided an almost
million-fold decrease of the sequence data (Table 1),
which made analysis of these large data sets possible
while still maintaining a very high sensitivity, granting us
the ability to apply sensitive assembly algorithms to
stitch together the identified fragments. Because our
method allows studies of all individual metagenomic se-
quence fragments without prior assembly, it is in a bet-
ter position to identify fragments from low abundance
sequences. Normally, fragments from lowly abundant se-
quences potentially risk being discarded as assembly
chaff when all sequence data is assembled simultan-
eously. Our approach is therefore well-suited also for
screening of future metagenomes with even higher se-
quencing depth.
Conclusions
We screened more than 12 terabases of DNA for novel
qnr fluoroquinolone resistance genes and were able to
identify 20 putatively novel qnr genes. Of the nine se-
lected for experimental validation, six consistently
showed an increased MIC to ciprofloxacin at levels com-
parable to previously established qnr variants when
expressed in E. coli. Our results thus expand the number
of qnr gene variants and further elucidates the diversity
of this important class of resistance genes. The results
also reinforce the hypothesis that environmental bacter-
ial communities act as sources of previously uncharac-
terized qnr genes. Identification of novel antibiotic
resistance genes before they are mobilized and trans-
ferred to human pathogens enables surveillance at an
early stage, facilitating implementation of preventive ac-
tions to counter the spread of new variants of multiresis-
tant bacteria in clinical environments.
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